Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II trial of autologous TriMix-DC in resected stage III/IV melanoma
2011-001410-33Phase 2Completed
- Sponsor
- UZ Brussel
- Start
- May 2011
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of TriMix-DC in melanoma (2 arms), sponsored by UZ Brussel. Started May 2011; status: completed.
02
Drugs
TriMix-DC
03
Conditions
melanoma
Beyond the preview
Go deeper on 2011-001410-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001410-33.